Le céramide à l'origine de la cardiotoxicité de la doxorubicine.
| dc.contributor.author | Andrieu-Abadie, N | fr_FR |
| dc.contributor.author | Levade, T | fr_FR |
| dc.contributor.author | Laurent, G | fr_FR |
| dc.contributor.author | Hatem, S | fr_FR |
| dc.contributor.author | Mercadier, JJ | fr_FR |
| dc.date.accessioned | 2012-08-23T13:55:46Z | |
| dc.date.available | 2012-08-23T13:55:46Z | |
| dc.date.issued | 1999 | fr_FR |
| dc.identifier.citation | Andrieu-Abadie, N - Levade, T - Laurent, G - Hatem, S - Mercadier, JJ, Le céramide à l'origine de la cardiotoxicité de la doxorubicine., Med Sci (Paris), 1999, Vol. 15, N° 11; p.1322-4 | fr_FR |
| dc.identifier.issn | 1958-5381 | fr_FR |
| dc.identifier.uri | http://hdl.handle.net/10608/1269 | |
| dc.language.iso | fr | fr_FR |
| dc.publisher | Masson Périodiques, Paris | fr_FR |
| dc.rights | Article en libre accès | fr |
| dc.rights | Médecine/Sciences - Inserm - SRMS | fr |
| dc.source | M/S. Médecine sciences [revue papier, ISSN : 0767-0974], 1999, Vol. 15, N° 11; p.1322-4 | fr_FR |
| dc.title | Le céramide à l'origine de la cardiotoxicité de la doxorubicine. | fr |
| dc.title.alternative | Doxorubicine alters cardiac myocyte through the ceramide pathway ? | fr_FR |
| dc.type | Article | fr_FR |
| dc.contributor.affiliation | Inserm C. 460, Faculte Xavier-Bichat, 76, rue Henri-Huchard, 75870 Paris, France; Inserm U. 466, CHU Rangueil, 1, avenue Jean-Poulhes, 51403 Toulouse, France; Inserm U. 466, CHU Rangueil, 1, avenue Jean-Poulhes, 31403 Toulouse, France; Inserm E9910, Institut Claudius-Regaud, 20, rue du Pont-Saint-Pierre, 31052 Toulouse, France; Inserm U. 460, faculte Xavier-Bichat, 16, rue Henri-Huchard, 75870 Paris, France; Inserm U. 460, Faculte Xavier-Bichat, 16, rue Henri-Huchard, 75018 Paris, France | - |
| dc.identifier.doi | 10.4267/10608/1269 |
